Cefdinir Impurity 21 | CAS 73150-67-1 - Request Quote
Cefdinir Impurity 21
| SZ CAT No: | SZ-C020044 |
| CAS No | 73150-67-1 |
| Mol.F. | C5H4N2O3S |
| Mol.Wt. | 172.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 80246-01-1 (HCl salt) ; 87328-92-5 (sodium salt) ; 126534-28-9 (potassium salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cefdinir Impurity 21 is chemically 2-(2-aminothiazol-4-yl)-2-oxoacetic acid. Cefdinir Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Cefdinir Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefdinir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 73150-67-1
Purchase 73150-67-1
Order 73150-67-1
Enquire 73150-67-1
price of 73150-67-1
73150-67-1 Supplier
73150-67-1 Manufacturer
73150-67-1 Exporter
buy high quality Cefdinir Impurity 21
Purchase Cefdinir Impurity 21
Cefdinir Impurity 21 suppliers
Cefdinir Impurity 21 manufacturers
Cefdinir Impurity 21 price
Order Cefdinir Impurity 21
Enquire Cefdinir Impurity 21
Cefdinir Impurity 21 cost
Cefdinir Impurity 21 Supplier
Cefdinir Impurity 21 Distributor
Cefdinir Impurity 21 for Method Validation
Cefdinir Reference Standard
Cefdinir Impurity 21 for ANDA Filing
Cefdinir Impurity 21 for Forced Degradation Studies
Cefdinir Impurity 21 Identification Standards
Cefdinir Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.